The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world cost-effectiveness of first-line gemcitabine + nab-paclitaxel versus FOLFIRINOX in patients with advanced pancreatic cancer: A population-based retrospective cohort study in Ontario, Canada.
 
Vanessa Arciero
No Relationships to Disclose
 
Jin Luo
No Relationships to Disclose
 
Ambika Parmar
No Relationships to Disclose
 
Wei Fang Dai
No Relationships to Disclose
 
Jaclyn M. Beca
No Relationships to Disclose
 
Michael J. Raphael
No Relationships to Disclose
 
Wanrudee Isaranuwatchai
No Relationships to Disclose
 
Steven Habbous
No Relationships to Disclose
 
Mina Tadrous
No Relationships to Disclose
 
Craig Earle
No Relationships to Disclose
 
Jim Biagi
No Relationships to Disclose
 
Nicole Mittmann
No Relationships to Disclose
 
Jessica Arias
No Relationships to Disclose
 
Scott Gavura
No Relationships to Disclose
 
Kelvin K. Chan
No Relationships to Disclose